Technologies

IDMIT core facilities

The IDMIT technological and research center will cover an area of more than 4690 square meters, housing research laboratories and monitoring platforms in BSL2 and BSL3 containment conditions, together with facilities for non-human primates, suitable for experimental infection with class 2 and class 3 human pathogens, including the agents of transmissible respiratory diseases. IDMIT Architectural project.

The center will provide external partners, including public academic institutions and private companies, with access to its facilities, for the achievement of their R&D projects, the testing of new products, the development of prototypes and the performance of pilot studies, in accordance with quality assurance requirements for future industrialization and release onto the market. Quality criteria will be met with the assistance of Bertin Pharma, a company specializing in assay standardization and quality assurance.

Highly innovative technologies, such as mass cytometry and in vivo imaging (MRI, PET-CT) of the host and pathogens will be developed, building on the expertise of the founder members in infectious disease models, existing facilities on the site and the know-how of the Molecular Imaging Research Center. A  Center of Biological Resources (CRB) has been be created. The major objective of this consortium is to provide the national and international scientific community with a highly competitive infrastructure for preclinical research, facilitating the discovery of markers of safety and efficacy for new vaccines and treatments and accelerating the translation of innovations from the bench into clinical practice.

 

                    06-New-graph-IDMIT-16-12-14 copie